Madrigal Pharmaceuticals · 1 week ago
Director, Data Architecture Development
Madrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Director, Commercial Data Architecture Development will lead key development initiatives within Madrigal’s Commercial Data Warehouse, serving as both architect and team lead for developers to drive the design and implementation of scalable data solutions that support commercial reporting and analytics.
BiopharmaBiotechnologyMedical DevicePharmaceutical
Responsibilities
Lead the design, build, and implementation of key programs leveraging Microsoft Fabric, Databricks, Synapse, and related tools
Serve as architect and technical team lead, providing hands-on development and guidance to data engineers in building efficient, scalable data pipelines
Define and implement data architecture frameworks aligned with Medallion (Bronze, Silver, Gold) principles
Design and oversee ETL/ELT processes for transformation of commercial datasets
Maintain data quality, integrity, and governance processes across all commercial data assets
Collaborate with Commercial Operations, Market Access, Analytics, and IT teams to ensure the data environment supports reporting and analytical needs
Define data modeling standards, master data management approaches, and harmonization across multiple data domains
Develop and maintain metadata management and documentation for the Commercial Data Warehouse
Partner with internal and external technology resources to optimize performance and scalability
Continuously evaluate and enhance architecture design to meet evolving business and analytical requirements
Qualification
Required
Bachelor's degree in Computer Science, Information Systems, Data Engineering, or a related discipline
Minimum of 15 years of experience in pharmaceutical commercial data management, data engineering, or data architecture roles
Proven track record designing and developing commercial data warehouses in cloud environments, preferably Microsoft Azure
Expertise with Azure Synapse, Databricks, Fabric, SQL, and Power BI integration
Deep understanding of pharmaceutical commercial datasets, including: Patient-level data (APLD): IQVIA, Komodo, PurpleLab, etc.; Formulary data: MMIT; Projected national data: Xponent, NSP, NPA, etc.; International data: MIDAS; Drug distribution data: IQVIA DDD; Reference data: OneKey, OpenData; Specialty pharmacy / Specialty distributor data (SP/SD)
Strong understanding of data modeling, performance tuning, and Medallion architecture design principles
Hands-on technical development experience with the ability to function as both architect and lead developer
Excellent problem-solving, communication, and cross-functional collaboration skills
Preferred
Experience within or providing consulting support for launch-stage or growth-stage biotech organizations
Familiarity with data tokenization and privacy compliance (e.g., Datavant)
Experience implementing data governance frameworks and metadata management
Demonstrated ability to mentor and provide technical direction to development teams
Benefits
Flexible paid time off
Medical
Dental
Vision and life/disability insurance
401(k) offerings (i.e., traditional, Roth, and employer match)
Supplemental life insurance
Legal services
Mental health benefits through our Employee Assistance Program for employees and their family
Company
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
H1B Sponsorship
Madrigal Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.94BKey Investors
Blue OwlHercules Capital
2025-07-22Post Ipo Debt· $350M
2024-03-18Post Ipo Equity· $690M
2023-09-28Post Ipo Equity· $500M
Recent News
The Motley Fool
2026-01-07
2026-01-06
MarketScreener
2026-01-03
Company data provided by crunchbase